Case 82 PerkinElmer, Inc.

PerkinElmer, Inc. is a leading provider of products, services, and solutions for the diagnostics, life sciences, and applied markets. The modern PerkinElmer (Revvity, Inc.) is focused in the business areas of diagnostics, life science research, food, and environmental and industrial testing. The company is headquartered in Massachusetts. The products and services are marketed in more than 190 countries. By Jan 2023, the company has employed approximately 16,700 employees. The stock is listed on the New York Stock Exchange. The company is included in the S&P 500 Index. PerkinElmer is a global leader in analytical testing which offers a comprehensive portfolio of complete solutions consisting of systems, software, consumables, and on-site and online services. This diagnostics and life sciences company addresses critical issues through advanced technologies and differentiated solutions. The life sciences segment consists of automation and liquid handling solutions and analysis and characterization. Automation and liquid handling solutions consists of integrated laboratory automation, liquid handling solution, and OEM solutions. Analysis and characterization consists of atomic spectroscopy, chromatography, and molecular spectroscopy. The diagnostic segment develops diagnostics, tools, and applications related to reproductive health, immunodiagnostics, and applied genomics markets. The total cumulative monthly returns for PerkinElmer were 73% for Perkin stock compared to 30% return given by the market index Nasdaq Biotechnology during the 5-year period June 2018 to May 2023.